title: The long journey from stem cells to medical product.
abstract: There is much interest in developing stem cells and the cells derived from them as therapies for treating human disease and injury, but many biological, technological and regulatory hurdles have to be overcome before these cell therapies can be brought to commercial fruition.
authors.affiliation: South Dartmouth, Massachusetts, USA.
authors.forename: Ann
authors.initials: A
authors.lastname: Parson
mesh_terms: D064987:Cell- and Tissue-Based Therapy / Q000592:standards* / Q000639:trends*; D006801:Humans; D044968:Regenerative Medicine / Q000331:legislation & jurisprudence / Q000592:standards / Q000639:trends; D013234:Stem Cells / Q000166:cytology* / Q000378:metabolism*; D014481:United States; D014486:United States Food and Drug Administration / Q000331:legislation & jurisprudence